Clinical Trial: Liq-NOL Efficacy in Pediatric Patients With Down Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Evaluation of Coenzyme q10 (Liq-nol®) Efficacy in Pediatric Patients With Down Syndrome

Brief Summary: The purpose of this study is to measure the effects of LiQ-NOL supplementation on language production using the Clinical Evaluation of Language Fundamentals test, language sampling using the mean length of utterance test, and speech articulation using the Goldman-Fristoe Test of Articulation.

Detailed Summary:
Sponsor: Children's Hospital Medical Center, Cincinnati

Current Primary Outcome: To measure the effects of LiQ-NOL on language skills, expressive language ability, and speech articulation. [ Time Frame: beginning and end of 3 month treatment period ]

Original Primary Outcome: Same as current

Current Secondary Outcome: To evaluate the effects of LiQ-NOL on child behavior. [ Time Frame: beginning and end of 3 month treatment period ]

Original Secondary Outcome: Same as current

Information By: Children's Hospital Medical Center, Cincinnati

Dates:
Date Received: April 29, 2009
Date Started: January 2005
Date Completion:
Last Updated: January 27, 2014
Last Verified: January 2014